Wasatch Advisors’s Outset Medical OM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-6,444
Closed -$1.54M 267
2022
Q3
$1.54M Sell
6,444
-69,962
-92% -$18.7M 0.01% 233
2022
Q2
$17M Buy
76,406
+29,389
+63% +$12.6M 0.11% 143
2022
Q1
$32M Sell
47,017
-14,623
-24% -$8.8M 0.16% 118
2021
Q4
$42.6M Buy
61,640
+33,873
+122% +$25.1M 0.17% 114
2021
Q3
$20.6M Buy
+27,767
New +$18.9M 0.08% 172

Other funds holding OM

Wasatch Advisors's OM Position: Q4 2022 in Review

Wasatch Advisors sold out of Outset Medical (OM) in Q4 2022, closing a stake of 6,444 shares — an estimated $1.54M sold.

Wasatch Advisors first reported a position in OM in Q3 2021 and held it in 5 quarters. The position peaked at $42.6M in Q4 2021. 151 funds tracked by Wall St. Rank hold OM as of Q4 2022.

  • Wasatch Advisors reported no remaining Outset Medical position as of Q4 2022 after selling out during the quarter.
  • Wasatch Advisors sold 6,444 Outset Medical shares in Q4 2022, an estimated $1.54M.
  • Wasatch Advisors first reported a position in Outset Medical in Q3 2021 and held it in 5 quarters.
  • Wasatch Advisors's Outset Medical position peaked at $42.6M in Q4 2021.
  • 151 funds tracked by Wall St. Rank held Outset Medical as of Q4 2022.

Based on Wasatch Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.